The clinical nail care products market is projected to grow from USD 2.3 billion in 2026 to USD 4.4 billion by 2036, at a CAGR of 6.8%. Medicated nail solutions will dominate with a 28.0% market share, while onychomycosis will lead the clinical indications segment with a 34.0% share.